In today’s recent session, 2.36 million shares of the Mangoceuticals Inc (NASDAQ:MGRX) have been traded, and its beta is 1.15. Most recently the company’s share price was $2.93, and it changed around -$1.82 or -38.21% from the last close, which brings the market valuation of the company to $15.17M. MGRX at last check was trading at a discount to its 52-week high of $16.80, offering almost -473.38% off that amount. The share price’s 52-week low was $2.07, which indicates that the recent value has risen by an impressive 29.35% since then. We note from Mangoceuticals Inc’s average daily trading volume that its 10-day average is 76210.0 shares, with the 3-month average coming to 96.26K.

Mangoceuticals Inc (NASDAQ:MGRX) trade information

Instantly MGRX has been showing red trend so far today with a performance of -38.21% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.20 on recent trading dayincreased the stock’s daily price by 43.65%. The company’s shares are currently up 21.28% year-to-date, but still down -18.92% over the last five days. On the other hand, Mangoceuticals Inc (NASDAQ:MGRX) is -36.20% down in the 30-day period. We can see from the shorts that 62722.0 shares have been sold at a short interest cover period of 0.41 day(s).

Mangoceuticals Inc (NASDAQ:MGRX)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 35.69% of Mangoceuticals Inc shares, and 1.79% of them are in the hands of institutional investors. The stock currently has a share float of 2.78%.

Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 6.51 shares worth $19783.0, making up 0.13% of all outstanding shares. On the other hand, Fidelity Total Market Index Fund held roughly 3.25 shares worth around $9864.0, which represents about 0.06% of the total shares outstanding.